Choose Transparency: A message to the Members...
The Clinical Trial Regulation is currently being discussed. As patients, researchers, doctors, scientists and civil society representatives we would like to draw your attention not only to the dangers it encompasses but also to the opportunities it brings along.
Clinical Trials Regulation Protect public...
The International Society of Drug Bulletins issued a statement today to the members of European Parlament to request:
- support amendments that require the public disclosure of a complete clinical studyreport (CSR) as outlined by ENVI rapporteur MEP...
New Proposal for a Regulation on Clinical Trials
The protection of human subjects must be upheld & citizens’ right to information must be strengthened
European Medicines Agency and...
On 18 June 2012, the EU Commission published a draft concept paper for public consultation on the “Introduction of fees to be charged by the European Medicines Agency for pharmacovigilance”.
for members only
Campaigns - Regulatory issues
European Medicines Agency and pharmacovigilance: no to a fee-for-service system
On 18 June 2012, the EU Commission published a draft concept paper for public consultation on the “Introduction of fees to be charged by the European Medicines Agency for pharmacovigilance”.
Regrettably, the European Medicines Agency (EMA) is being turned into a mere provider of services to the pharmaceutical industry. Other strategies for funding that would help drug regulatory agencies to be more independent do exist. They should be carefully considered.
Latest Campaigns
-
Choose Transparency: A message to the Members...
April 23rd 2013 - Regulatory issues
The Clinical Trial Regulation is currently being discussed. As patients, researchers, doctors, scientists and civil society...
-
Clinical Trials Regulation Protect public...
April 9th 2013 - Regulatory issues
The International Society of Drug Bulletins issued a statement today to the members of European Parlament to...
-
New Proposal for a Regulation on Clinical Trials
February 5th 2013 - Regulatory issues
The protection of human subjects must be upheld & citizens’ right to information must be strengthened
-
European Medicines Agency and...
September 15th 2012 - Regulatory issues
On 18 June 2012, the EU Commission published a draft concept paper for public consultation on the “Introduction of fees to be...
-
Comments on Quality Review of Documents (QRD):...
August 16th 2012 - Regulatory issues
Submission of comments on 'Quality Review of Documents (QRD) human product information annotated template: revision of the product...
ISDB - International Society of Drug bullettins
Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it
© 2013